Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
8 Stocks Moved By Traders On ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Carlyle Group’s Return On Capital Employed Overview
Pulled from Benzinga Pro data, Carlyle Group (NASDAQ:CG) posted Q1 earnings of $594.80 million, an increase from Q4 of 9.93%. Sales dropped to $779.50 million, a 58.87% decrease between quarters.
What 4 Analyst Ratings Have To Say About Carlyle Group
Within the last quarter, Carlyle Group (NASDAQ:CG) has observed the following analyst ratings:
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
10 Stocks Moved By Traders On Thursday’s CNBC’s ‘Fast Money: Halftime Report’
CNBC’s ‘Fast Money: Halftime Report’ delivers market-moving news to investors.
Traders Moved These Stocks On Tuesday’s CNBC’s ‘Fast Money: Halftime Report’
CNBC’s ‘Fast Money: Halftime Report’ delivers market-moving news to investors.
Here’s How Much You Would Have Made Owning Carlyle Group Stock In The Last 5 Years
Carlyle Group (NASDAQ:CG) has outperformed the market over the past 5 years by 8.65% on an annualized basis producing an average annual return of 22.49%. Currently, Carlyle Group has a market capitalization of $15.92 billion.